Protein synthesis entails intermediary ribonucleic acid (RNA) polymers.

Ribonucleic acid, or RNA, is a nucleic acid polymer consisting of nucleotide monomers, which plays several important roles in the processes of transcribing genetic information from deoxyribonucleic acid (DNA) into proteins.

Traditional drug encapsulation has been done using lactic acid polymers.

The Davis & Geck branch developed the first synthetic absorbable suture, trademarked Dexon, during the 1970s, based on an ingenious glycolic acid polymer (thus utilizing a natural body protein, which reduced inflammation and scarring).

An antisense oligonucleotide is a synthesized short nucleic acid polymer, typically fifty or fewer base pairs in length that will bind to the mutation site in the pre-messenger RNA, to induce exon skipping.

Another proposal is that the dual molecule system we see today, where a nucleotide-based molecule is needed to synthesize protein, and a protein-based molecule is needed to make nucleic acid polymers, represents the original form of life.

Oxidative injury induced by synthetic humic acid polymer and monomer in cultured rabbit articular chondrocytes.

Cereplast uses corn, tapioca, potatoes and algae, including polylactic acid polymer (PLA), to produce compostable plastic resins designed to serve as an alternative to petroleum-based plastics.

The commercial quality polymer is made from the carbon found in simple plant sugars to create a proprietary polylactic acid polymer (PLA) which is marketed under the brand name Ingeo.

HAS2 is responsible for very large hyaluronic acid polymers, while smaller sizes of HA are synthesized by HAS1 and HAS3.